Home Cart 0 Sign in  
X

[ CAS No. 1126-00-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1126-00-7
Chemical Structure| 1126-00-7
Chemical Structure| 1126-00-7
Structure of 1126-00-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1126-00-7 ]

Related Doc. of [ 1126-00-7 ]

Alternatived Products of [ 1126-00-7 ]

Product Details of [ 1126-00-7 ]

CAS No. :1126-00-7 MDL No. :MFCD00003112
Formula : C9H8N2 Boiling Point : -
Linear Structure Formula :- InChI Key :WITMXBRCQWOZPX-UHFFFAOYSA-N
M.W : 144.17 Pubchem ID :70769
Synonyms :

Calculated chemistry of [ 1126-00-7 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.56
TPSA : 17.82 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.62 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.89
Log Po/w (XLOGP3) : 2.2
Log Po/w (WLOGP) : 1.87
Log Po/w (MLOGP) : 1.73
Log Po/w (SILICOS-IT) : 1.6
Consensus Log Po/w : 1.86

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.79
Solubility : 0.232 mg/ml ; 0.00161 mol/l
Class : Soluble
Log S (Ali) : -2.21
Solubility : 0.892 mg/ml ; 0.00619 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.9
Solubility : 0.18 mg/ml ; 0.00125 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.14

Safety of [ 1126-00-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1126-00-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1126-00-7 ]
  • Downstream synthetic route of [ 1126-00-7 ]

[ 1126-00-7 ] Synthesis Path-Upstream   1~17

  • 1
  • [ 1126-00-7 ]
  • [ 17635-45-9 ]
Reference: [1] Gazzetta Chimica Italiana, 1956, vol. 86, p. 797,808
  • 2
  • [ 1126-00-7 ]
  • [ 68-12-2 ]
  • [ 132274-70-5 ]
YieldReaction ConditionsOperation in experiment
90%
Stage #1: With n-butyllithium In tetrahydrofuran; n-heptane at -78℃; for 2 h;
Stage #2: at -78 - 20℃; for 19 h;
Stage #3: With water In n-heptane; water
Example A: 1-Phenylpyrazole-5-carbaldehyd; Experimental procedure:; Under N2-atmosphere a solution of n-butyllithium in heptane (2.61 M, 5.3 mL, 13.9 mmol) is slowly added to a cooled (- 78 °C) solution of 1-phenyl-1H-pyrazole (2.0 g, 13.9 mmol) in abs. THF (60 mL). The reaction mixture was stirred for 2 h at -78 °C. Subsequently a Solution of abs. DMF (1.1 mL, 13.9 mmol) in abs. THF (8 mL) is slowly added at -78 °C. This mixture was stirred for 1 h at -78 °C, before it was slowly heated to room temperature and was stirred for a further 18 h. Then it was hydrolysed with water (10 mL) and subsequently extracted three times with CH2Cl2. The organic phases were dried (Na2SO4), filtered and the solvent was removed under vacuum. The crude product (2.48 g) was purified using flash-chromatography (OE= 6 cm, h = 12 cm, n-hexane:ethylacetate = 8:2, 30 mL, Rf = 0.24). Yellow Oil, that crystalized in the cold to a yellow solid, melting point: 31 °C, Yield: 2.15 g (90percent) C10H8N2O (172.2) MS (EI): m/z (rel.Int) = 172 [M+, 100], 144 [M - CO, 69]. IR (neat): ν (cm-1) = 3063 (C-H aromat.), 2923 (C-H aliphat.), 2854 (C-H), 1683 (C=O), 1596, 1517, 1499 (C=C), 763, 694 (C-H). 1H-NMR (CDCl3): δ (ppm) = 7.11 (d, J = 2.1 Hz, 1H, Pyrazole-4-CH), 7.46 - 7.56 (m, 5H, Phenyl-CH), 7.76 (d, J = 2.0 Hz, 1H, Pyrazole-3-CH), 9.88 (s, 1 H, CHO). 13C-NMR (CDCl3): δ (ppm) = 112.5 (1 C, Pyrazole-4-CH), 125.8 (2 C, Phenyl-CH, ortho), 129.4 (1 C, Phenyl-CH, para), 129.6 (2 C, Phenyl-CH, meta), 139.0 (1 C, Phenyl-C, quartaer), 140.3 (1 C, Pyrazole-5-C), 140.7 (1 C, Pyrazole-3-CH), 180.2 (1 C, CHO).
Reference: [1] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 6, p. 2992 - 3001
[2] Patent: EP1982987, 2008, A1, . Location in patent: Page/Page column 13-14; 18-19
[3] Journal of Medicinal Chemistry, 2011, vol. 54, # 19, p. 6704 - 6713
[4] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1990, # 10, p. 2749 - 2750
  • 3
  • [ 823-96-1 ]
  • [ 1126-00-7 ]
  • [ 20157-44-2 ]
Reference: [1] Journal of the American Chemical Society, 2006, vol. 128, # 39, p. 12634 - 12635
  • 4
  • [ 1126-00-7 ]
  • [ 75-16-1 ]
  • [ 20157-44-2 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 19, p. 5458 - 5461
  • 5
  • [ 124-38-9 ]
  • [ 1126-00-7 ]
  • [ 6063-88-3 ]
  • [ 18107-18-1 ]
  • [ 20157-44-2 ]
  • [ 1262659-73-3 ]
  • [ 400750-34-7 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 5, p. 1251 - 1253
  • 6
  • [ 124-38-9 ]
  • [ 1126-00-7 ]
  • [ 6063-88-3 ]
  • [ 20157-44-2 ]
  • [ 55317-53-8 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 5, p. 1251 - 1253
  • 7
  • [ 1126-00-7 ]
  • [ 15115-52-3 ]
YieldReaction ConditionsOperation in experiment
97%
Stage #1: With bromine In acetic acid; ethyl acetate at 100℃; for 8 h;
Stage #2: With sodium hydrogencarbonate In water at 0 - 20℃;
EXAMPLE 29A
4-Bromo-1-phenyl-1H-pyrazole
To 1-phenylpyrazole (Aldrich, 1 g, 6.94 mmol) in 10 mL acetic acid was added 1.1 g of Br2 (Fisher, 6.94 mmol) in 10 mL acetic acid.
This mixture was warmed to 100° C. in a pressure tube for 8 h.
The material was cooled to ambient temperature, poured into ice and H2O in a 500 mL beaker and excess saturated, aqueous NaHCO3 was added until all the acetic acid had been quenched. EtOAc (50 mL) was added and the layers were separated.
The aqueous layer was extracted 2*15 mL EtOAc and the combined organics were dried over Na2SO4 and concentrated under reduced pressure to give a crude solid.
Purification via flash column chromatography (SiO2, 50percent hexanes-EtOAc) gave 1.5 g of the title compound (6.72 mmol, 97percent yield). MS (DCI/NH3) m/z 223, 225 (M+H)+.
97% With bromine In acetic acid at 100℃; for 8 h; Example 257A
4-Bromo-1-phenyl-1H-pyrazole
A solution of bromine (1.1 g, 6.94 mmol) in acetic acid (10 mL) was added to a mixture of 1-phenylpyrazole (Aldrich, 1 g, 6.94 mmol) in acetic acid (10 mL).
This mixture was warmed to 100° C. in a pressure tube for 8 h.
The material was cooled to ambient temperature, poured into ice and H2O neutralized with excess saturated, aqueous NaHCO3.
Ethyl acetate (50 mL) was added and the layers were separated.
The aqueous layer was extracted with EtOAc (2*15 mL) and the combined organic extract was dried over Na2SO4 and concentrated under reduced pressure to give a crude solid.
Purification by column chromatography (SiO2, 50percent hexanes-EtOAc) provided the title compound (1.5 g, 6.72 mmol, 97percent yield). MS (DCl/NH3) m/z 223, 225 (M+H)+.
Reference: [1] Chemistry - A European Journal, 2015, vol. 21, # 34, p. 11976 - 11979
[2] Patent: US2005/65178, 2005, A1, . Location in patent: Page/Page column 31
[3] Patent: US2005/101602, 2005, A1, . Location in patent: Page/Page column 68
[4] RSC Advances, 2016, vol. 6, # 93, p. 90031 - 90034
[5] Tetrahedron Letters, 2007, vol. 48, # 26, p. 4595 - 4599
[6] Organic Letters, 2015, vol. 17, # 12, p. 2886 - 2889
[7] Journal of Medicinal Chemistry, 2016, vol. 59, # 10, p. 4711 - 4723
[8] Gazzetta Chimica Italiana, 1889, vol. 19, p. 131[9] Chemische Berichte, 1890, vol. 23, p. 1452
  • 8
  • [ 1126-00-7 ]
  • [ 68-12-2 ]
  • [ 54605-72-0 ]
YieldReaction ConditionsOperation in experiment
90% at 100℃; 2) The 7.3 g (0.1 µM) DMF is added to the 250 ml three-opening in the bottle, cryohydrate under bath after stirring, dropping 15.4 g (0.1 µM) phosphorus oxychloride, 1 h after dropwise 2.88 g (0.02 µM) N - phenyl pyrazole, heating up to 100 °C reflux, the reaction 3 - 6 hours, TLC monitoring after the reaction, the reaction the patient into the ice water, carbonate sodium accent to the neutral, adding (3 × 50 ml) ethyl acetate extraction, the organic phase with saturated salt water 50 ml washing, desolvation residue after column chromatography (eluting agent is ethyl acetate with petroleum ether (reflux 60 - 90 °C), the volume ratio of 1:5), shall be 3.10 g white solid, yield 90.0percent.
37%
Stage #1: at 0℃; for 1.2 h;
Stage #2: at 0 - 100℃; for 2.86667 h;
Procedure: (Vilsmeier-type formylation reaction) A 100 ml reactor, under nitrogen and with magnetic stirring, is loaded with 10 ml of DMF which are immediately cooled to 0° C. by means of an ice/water bath. The phosphorus oxychloride is added dropwise, by means of a syringe, in 12 minutes. After 1 hour at 0° C., a solution of 1-phenylpyrazole (in 10 ml of DMF) is added in 2 minutes by means of a syringe, by rapidly running it in dropwise. After a further 5 minutes at 0° C., the mixture is brought back to ambient temperature for 15 minutes and then placed at 100° C. for 2 h 30 min. Complete disappearance of the starting product is observed by TLC (9/1 hexane/acetic acid (EtOAc): Rf: 0.35). Once it has returned to ambient temperature, the reaction medium is carefully added to 20 g of ice-cold water, under a hood. After stirring for 18 hours, the mixture is extracted twice with 250 ml of ethyl acetate. The combined organic phases are dried over sodium sulfate, filtered through a sintered glass filter, and evaporated to dryness, and the residue is then filtered through a patch of silica on a sintered glass filter (elution: pure hexane, 8/2 hexane/CH2Cl2, 1/1 hexane/CH2Cl2, 100percent CH2Cl2). The purely chlorinated fractions make it possible to isolate 1.17 g of a yellow oil, which crystallizes spontaneously once taken up in hexane. A second fraction (eluted with 1/1 hexane/CH2Cl2) taken up with hexane also makes it possible to isolate a solid. The solids are combined and washed three times with 10 ml of hexane so as to obtain 2.21 g of a white solid (yield 37percent).
Reference: [1] Patent: CN107964007, 2018, A, . Location in patent: Paragraph 0498
[2] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 1, p. 295 - 302
[3] Journal of Heterocyclic Chemistry, 1993, vol. 30, # 4, p. 957 - 960
[4] Patent: US2006/34786, 2006, A1, . Location in patent: Page/Page column 62
[5] Synthetic Communications, 1998, vol. 28, # 7, p. 1299 - 1321
[6] Tetrahedron, 2001, vol. 57, # 20, p. 4397 - 4403
[7] Patent: US2009/239810, 2009, A1, . Location in patent: Page/Page column 72
  • 9
  • [ 100-97-0 ]
  • [ 1126-00-7 ]
  • [ 54605-72-0 ]
Reference: [1] Synthetic Communications, 2013, vol. 43, # 12, p. 1633 - 1639
[2] Chemical Biology and Drug Design, 2017, vol. 90, # 3, p. 432 - 442
[3] Inflammopharmacology, 2018, vol. 26, # 1, p. 217 - 226
[4] Life Sciences, 2012, vol. 90, # 23-24, p. 910 - 916
  • 10
  • [ 1126-00-7 ]
  • [ 497-19-8 ]
  • [ 54605-72-0 ]
Reference: [1] Journal of the Brazilian Chemical Society, 2011, vol. 22, # 2, p. 352 - 358
  • 11
  • [ 1126-00-7 ]
  • [ 76-05-1 ]
  • [ 54605-72-0 ]
YieldReaction ConditionsOperation in experiment
0.72 g Inert atmosphere; Reflux A solution of 1-phenylpyrazole (2.0g, 13.87 mmoles) in TFA (l7mL) was stirred under a nitrogen atmosphere and treated with. hexamethylene tetramine (2.92 g, 20.81 mmoles). The reaction was refluxed overnight, and then cooled and poured into saturated sodium bicarbonate aqueous solution to adjust the pH to 7. The aqueous phase was extracted three times with ethyl acetate. The combined organic phases were washed with brine, dried overMgSO4, filtered and concentrated to 2.78 g of crude oil. Flash column chromatography on silica gel with a 40 gram Isco MPLC column using 10-20percent EtOAc-Hexanes gradient provided 0.72 g of the title compound.1H NMR ö 9.98 (s, 1H), 8.44(s, 1H), 8.17 (s, 1H), 7.70 (m, 2H), 7.5 (m,2H), 7.4 (m,1H).
Reference: [1] Patent: WO2015/89003, 2015, A1, . Location in patent: Page/Page column 44
  • 12
  • [ 1126-00-7 ]
  • [ 54605-72-0 ]
Reference: [1] Journal of the Chemical Society, 1954, p. 2293,2295
  • 13
  • [ 1126-00-7 ]
  • [ 1134-50-5 ]
Reference: [1] Synthesis, 1986, # 9, p. 753 - 755
[2] Journal of the Chemical Society, 1954, p. 2293,2295
[3] Inflammopharmacology, 2018, vol. 26, # 1, p. 217 - 226
  • 14
  • [ 1126-00-7 ]
  • [ 25688-18-0 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 27, p. 8470 - 8475
  • 15
  • [ 67-56-1 ]
  • [ 1126-00-7 ]
  • [ 102908-37-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 2, p. 1255 - 1262
  • 16
  • [ 1126-00-7 ]
  • [ 141998-92-7 ]
Reference: [1] Journal of Organic Chemistry, 2008, vol. 73, # 1, p. 177 - 183
  • 17
  • [ 1126-00-7 ]
  • [ 1238702-58-3 ]
Reference: [1] Patent: US2013/150344, 2013, A1,
[2] Patent: US2013/137700, 2013, A1,
[3] Patent: US2013/137675, 2013, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1126-00-7 ]

Aryls

Chemical Structure| 1128-54-7

[ 1128-54-7 ]

3-Methyl-1-phenyl-1H-pyrazole

Similarity: 0.90

Chemical Structure| 1128-56-9

[ 1128-56-9 ]

1-Phenyl-1H-pyrazol-3-amine

Similarity: 0.87

Chemical Structure| 687635-04-7

[ 687635-04-7 ]

(3-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.85

Chemical Structure| 368870-03-5

[ 368870-03-5 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.85

Chemical Structure| 132274-70-5

[ 132274-70-5 ]

1-Phenyl-1H-pyrazole-5-carbaldehyde

Similarity: 0.84

Related Parent Nucleus of
[ 1126-00-7 ]

Pyrazoles

Chemical Structure| 1128-54-7

[ 1128-54-7 ]

3-Methyl-1-phenyl-1H-pyrazole

Similarity: 0.90

Chemical Structure| 1128-56-9

[ 1128-56-9 ]

1-Phenyl-1H-pyrazol-3-amine

Similarity: 0.87

Chemical Structure| 687635-04-7

[ 687635-04-7 ]

(3-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.85

Chemical Structure| 368870-03-5

[ 368870-03-5 ]

(4-(1H-Pyrazol-1-yl)phenyl)methanamine

Similarity: 0.85

Chemical Structure| 132274-70-5

[ 132274-70-5 ]

1-Phenyl-1H-pyrazole-5-carbaldehyde

Similarity: 0.84